SwishX, an AI-powered content technology company serving the life sciences industry (pharma, biotech, and medtech organizations), announced the appointment of Melonie Warfel as Chief Commercial Officer.

Warfel will lead SwishX's commercial strategy, including sales, marketing, customer success, ...

West Pharmaceutical Services, Inc. a global leader in innovative solutions for injectable drug administration where it will highlight its leadership and expertise in addressing industry challenges.

"For over a century, West has partnered with the world's leading pharmaceutical companies to help ...

Ensera, a global CDMO specializing in commercialization support for injectable drug programs, has launched the Ensera Alliance Network, bringing together leading device platform and fill-finish specialists to address the complexity of commercializing drug-device combination products.

The ...

Upsher-Smith Laboratories, LLC a subsidiary of Bora Pharmaceuticals Co., Ltd. announced the recent launch of Fluvoxamine Maleate Extended-Release Capsules in 100 mg and 150 mg strengths. According to IQVIA, the Fluvoxamine Maleate Extended-Release market had U.S. sales of approximately $44.6 ...

Kivu Bioscience, a clinical-stage biotechnology company developing next-generation antibody-drug conjugates (ADCs) for difficult-to-treat cancers, announced the appointment of Mohit Trikha, Ph.D., as Chief Executive Officer. Dr. Trikha, who previously served as President and Chief Operating ...

OrthoFX™, a leader in innovative clear aligner technology, announced preliminary results from a retrospective clinical study comparing treatment effectiveness and predictability of its FXClear aligner system with the leading clear aligner brand, Invisalign. The study, titled "Treatment ...